Subscribe
shutterstock_333087503-creative-photo-corner
Creative Photo Corner / Shutterstock.com
26 March 2020Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

The Costa Rican government has asked the  World Health Organization (WHO) to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
WHO: 250 million COVID-19 tests to reach low-income countries
1 February 2021   More than 250 million rapid COVID-19 tests will be made available for low and middle-income countries as part of a World Health Organization initiative to accelerate the global response to the virus.
Europe
UK implored to back COVID-19 IP waiver at WTO
11 March 2021   The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.
Big Pharma
Australia backs COVID-19 vaccine waiver
9 September 2021   Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
WHO: 250 million COVID-19 tests to reach low-income countries
1 February 2021   More than 250 million rapid COVID-19 tests will be made available for low and middle-income countries as part of a World Health Organization initiative to accelerate the global response to the virus.
Big Pharma
Australia backs COVID-19 vaccine waiver
9 September 2021   Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.
Europe
UK implored to back COVID-19 IP waiver at WTO
11 March 2021   The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

More on this story

Americas
WHO: 250 million COVID-19 tests to reach low-income countries
1 February 2021   More than 250 million rapid COVID-19 tests will be made available for low and middle-income countries as part of a World Health Organization initiative to accelerate the global response to the virus.
Big Pharma
Australia backs COVID-19 vaccine waiver
9 September 2021   Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.
Europe
UK implored to back COVID-19 IP waiver at WTO
11 March 2021   The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner